Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Possinger

Showing results (131-140 of 166) with videos related to

Pageof 17
Sort By:
Bone Marrow Transplantation|May 25, 1999
Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell supportO Sezer, P Schmid, M Shweigert, et al.
Anticancer Research|September 2, 1999
The course of the urinary DPD-crosslink secretion in metastatic breast cancer--a possibility for response assessmentD Lüftner, S Günther, B Flath, et al.
Anticancer Research|January 12, 2000
Adjuvant high-dose chemotherapy with epirubicin and ifosfamide in nodal positive breast cancerD Lüftner, K Wagner, G Dingeldein, et al.
Infection|August 29, 2000
Disseminated mucormycosis caused by Absidia corymbifera leading to cerebral vasculitisJ Eucker, O Sezer, R Lehmann, et al.
Annals of Hematology|December 29, 2000
Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantationO Sezer, J Eucker, C Bauhuis, et al.
Journal of Cancer Research and Clinical Oncology|September 15, 2004
Orbital metastases in breast cancer: report of two cases and review of the literatureA Dieing, C-O Schulz, P Schmid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
The effect of increasing topotecan infusion from 30 minutes to 4 hours on the duration of exposure in cerebrospinal fluidW C Zamboni, D I Lüftner, M J Egorin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumorsP Schmid, P Kiewe, K Possinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II studyK Höffken, W Jonat, K Possinger, et al.
European Journal of Medical Research|November 15, 2000
Neuropathy under chemotherapyT Beinert, F Masuhr, E Mwela, et al.
Pageof 17

Showing results (131-140 of 166) with videos related to

Sort By:
Pageof 17
Bone Marrow Transplantation|May 25, 1999
Rapid reversal of nephrotic syndrome due to primary systemic AL amyloidosis after VAD and subsequent high-dose chemotherapy with autologous stem cell supportO Sezer, P Schmid, M Shweigert, et al.
Anticancer Research|September 2, 1999
The course of the urinary DPD-crosslink secretion in metastatic breast cancer--a possibility for response assessmentD Lüftner, S Günther, B Flath, et al.
Anticancer Research|January 12, 2000
Adjuvant high-dose chemotherapy with epirubicin and ifosfamide in nodal positive breast cancerD Lüftner, K Wagner, G Dingeldein, et al.
Infection|August 29, 2000
Disseminated mucormycosis caused by Absidia corymbifera leading to cerebral vasculitisJ Eucker, O Sezer, R Lehmann, et al.
Annals of Hematology|December 29, 2000
Patients with malignant lymphomas experience a higher rate of documented infections than patients with breast cancer after high-dose chemotherapy with autologous peripheral stem cell transplantationO Sezer, J Eucker, C Bauhuis, et al.
Journal of Cancer Research and Clinical Oncology|September 15, 2004
Orbital metastases in breast cancer: report of two cases and review of the literatureA Dieing, C-O Schulz, P Schmid, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
The effect of increasing topotecan infusion from 30 minutes to 4 hours on the duration of exposure in cerebrospinal fluidW C Zamboni, D I Lüftner, M J Egorin, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 3, 2009
Phase I study of the novel, fully synthetic epothilone sagopilone (ZK-EPO) in patients with solid tumorsP Schmid, P Kiewe, K Possinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1990
Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II studyK Höffken, W Jonat, K Possinger, et al.
European Journal of Medical Research|November 15, 2000
Neuropathy under chemotherapyT Beinert, F Masuhr, E Mwela, et al.
Pageof 17